MENINGITIS. As a condition of occupancy in University Housing, Pennsylvania law requires all students living in University Housing to receive a one-time vaccination against meningococcal disease commonly known as meningitis, OR, to sign a waiver that indicates that they are choosing to decline the vaccine. The required form must be signed electronically as part of the Housing/Dining Services Contract. Completion and return of this form is required for a student to receive a University Housing assignment. Forms may also be faxed to Panther Central at 000-000-0000.
MENINGITIS. Each new student residing in University housing is required by Colorado Statute to notify the University of his/her meningococcal vaccination status. Said students are required to make this notification on the housing application indicating whether or not the Student has received a meningococcal vaccination. The vaccination is voluntary; the decision to vaccinate is one the student, parent(s) or guardian(s) should make in consultation with their family health care provider. Meningococcal disease is a serious disease. Meningococcal disease is a contagious, but a largely preventable, infection of the spinal cord fluid and the fluid that surrounds the brain. Scientific evidence suggests that college students living in dormitory facilities are at a modestly increased risk of contracting meningococcal disease. Immunization against meningococcal disease decreases the risk of contracting the disease. If a student chooses not to be vaccinated for Meningitis and an outbreak occurs, the student will be required to move off campus at their own expense and continue to pay on campus housing and dining fees.
MENINGITIS. Each new, incoming freshman student residing in University housing is required by Colorado Statute to notify the University of his/her meningococcal vaccination status. Said students are required to make this notification on the housing application indicating whether or not the Student has received a meningococcal vaccination. The vaccination is voluntary; the decision to vaccinate is one the student, parent(s) or guardian(s) should make in consultation with their family health care provider. Meningococcal disease is a serious disease. Meningococcal disease is a contagious, but a largely preventable, infection of the spinal cord fluid and the fluid that surrounds the brain. Scientific evidence suggests that college students living in dormitory facilities are at a modestly increased risk of contracting meningococcal disease. Immunization against meningococcal disease decreases the risk of contracting the disease.
MENINGITIS. I agree to receive the one dose of vaccine by July 17, 2015 or submit the appropriate waiver.
MENINGITIS. Where a tumour, abscess or subarachnoid haemorrhage is suspected in a patient diagnosed with meningitis, an Out of Hours service may be requested without Consultant Consultation. If the patient has suspected raised ICP, it is recommended that empirical treatment is commenced after a blood culture. CT is unreliable in the diagnosis of raised ICP. Radiology On-CallPolicy
MENINGITIS. One type of meningitis is caused by a bacterium called Neisseria meningitidis. Infections caused by this bacterium are serious and may lead to death. Symptoms of an infection with Neisseria meningitides may include a high fever, headache, stiff neck, nausea, confusion, and rash. This disease can become severe very quickly and often leads to deafness, mental retardation, loss of arms or legs, and even death. The bacteria are spread from close person to person contact through the exchange of nose and throat secretions, by activities such as kissing or sharing eating or drinking utensils. The bacteria are not spread by casual contact or by simply breathing the air where a person with meningitis has been. There are two vaccines that can help prevent cases of this disease in teens and young adults. The United States Centers for Disease Control and Prevention (CDC) recommends vaccination of children with the meningococcal conjugate vaccine (Menactra and Menveo) at 11 or 12 years of age, with a booster dose of the vaccine at 16 years of age. The booster dose at age 16 provides ongoing protection from the disease after high school. The state of Indiana requires all students in grades 6-12 to have the appropriate number of meningococcal conjugate vaccine doses. One dose of meningococcal conjugate vaccine is required for all students in 6th -11th grade. A second booster dose is required for students entering 12th grade. These vaccines are a legal requirement for school entry (Indiana Administrative Code 410 IAC 1-1-1) for the 2019-2020 school year. All students in grades 6-12 must have acceptable documentation of required immunizations on record at the school they are currently attending. An acceptable record includes a signed record from the child’s health care provider indicating the name of the vaccine given and the date it was given, a record of the immunization in the state immunization registry (CHIRP) prior to the start of the school year, or a record from another school showing the required immunizations have been given. Many local health departments and private healthcare providers offer this vaccine. Please contact your health care provider for specific instructions regarding your child. More information about meningococcal disease can be found at: The Centers for Disease Control and Prevention (CDC) website: xxxx://xxx.xxx.xxx/vaccines/vpd-vac/mening/default.htm IN State Department of Health website: xxxx://xxx.xx.xxx/isdh/25455.htm NONDISCRIMINATION AND ...
